-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Initiates Coverage On Rhythm Pharmaceuticals with Hold Rating, Announces Price Target of $120

Benzinga·08/28/2026 12:58:56
Listen to the news
Deutsche Bank analyst David Hoang initiates coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Hold rating and announces Price Target of $120.